FDA, CDC identify potential infection risk prompting voluntary recall of syringes by BD Medical

Medical News
The following is an alert from BD Medical. Read the full consumer letter with detailed product information here.  

Out of an abundance of caution and in the interest of public health, BD is voluntarily recalling certain lots of BD PosiFlush™ Heparin Lock Flush and BD™ Pre-Filled Normal Saline Flush syringes due to a potential for contamination with Serratia marcescens bacterium. BD was notified by the U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) about a potential epidemiological link between catheter-related bloodstream infections and the S. marcescens bacterium. 
Specifically, the FDA and CDC identified a potential connection between reports of infection in a small number of patients caused by S. marcescens across multiple states. CDC’s initial investigation found that affected patients had received treatment using certain BD flush products. 
To date, there is no evidence of BD flush product testing positive for this bacterium. Investigations are ongoing by BD, FDA, and CDC. 
Read the full consumer letter with detailed recall dates here.